Ancora Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Ancora Advisors, LLC

$4.06 Billion
Q3 2024

A detailed history of Ancora Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ancora Advisors, LLC holds 156 shares of REGN stock, worth $118,062. This represents 0.0% of its overall portfolio holdings.

Number of Shares

156

Previous 155 0.65%

Holding current value

$118,062

Previous $162,000 0.62%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $1,024 - $1,201	1 Added 0.65%	156 $163,000
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $28,681 - $32,622	-37 Reduced 19.27%	155 $136,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $9,001 - $10,976	-13 Reduced 6.34%	192 $158,000
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $5,600 - $6,642	8 Added 4.06%	205 $147,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $27,219 - $33,078	40 Added 25.48%	197 $161,000
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $1,411 - $1,532	2 Added 1.29%	157 $113,000
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $1,096 - $1,477	-2 Reduced 1.27%	155 $92,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $63,677 - $74,732	-107 Reduced 40.53%	157 $110,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $53,560 - $62,858	90 Added 51.72%	264 $125,000
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $9,239 - $11,406	17 Added 10.83%	174 $110,000
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $6,888 - $8,171	-12 Reduced 7.1%	157 $95,000
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $44,916 - $53,061	-95 Reduced 35.98%	169 $94,000
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $7,626 - $9,214	14 Added 5.6%	264 $148,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $4,933 - $6,439	10 Added 4.17%	250 $156,000
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $16,809 - $24,721	50 Added 26.32%	240 $117,000
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $52,084 - $71,536	190 New	190 $71,000

Others Institutions Holding REGN

# of Institutions

1,524

Shares Held

84M

Call Options Held

1.14M

Put Options Held

1.48M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History